Tamsulosin-induced Hyperprolactinemia in a Patient with Multiple Sclerosis: A Case Report

  • Görgel A
  • Soylu A
  • Görgel S
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Drug-induced hyperprolactinemia is one of the most common causes of non-physiologic hyperprolactinemia. In contrary to other anterior pituitary hormones, prolactin is not controlled via hypothalamic-pituitary negative feedback mechanism. Since prolactin secretion is inhibited mainly by dopamine, some drugs such as antipsychotics and prokinetics which block dopamine receptors may lead to hyperprolactinemia. Nevertheless, despite this well-known phenomenon, most of cases of drug-induced hyperprolactinemia are asymptomatic. On the other hand, hyperprolactinemia due to tamsulosin that is an alpha adrenergic receptor antagonist has not been reported yet. Herein, we present a 39-year-old woman with multiple sclerosis who developed hyperprolactinemia after starting treatment with tamsulosin for neurogenic bladder disease.

Cite

CITATION STYLE

APA

Görgel, A., Soylu, A., Görgel, S., Tecellioğlu, M., & Sarıer, M. (2019). Tamsulosin-induced Hyperprolactinemia in a Patient with Multiple Sclerosis: A Case Report. Journal of Urological Surgery, 6(2), 156–158. https://doi.org/10.4274/jus.galenos.2018.2436

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free